AstraZeneca unveils positive results for major new cancer treatments

June 4, 2014 10:51 AM

5 0

LONDON — The chances of AstraZeneca developing future blockbuster drugs appeared to increase yesterday (June 3) as it reported positive results for the major new cancer treatments at the centre of last month’s successful defence against a £69 billion (S$145 billion) takeover proposal by Pfizer.

In a statement issued to the stock exchange yesterday morning, the Anglo-Swedish firm presented clinical data on its lung cancer treatments AZD9291 and MEDI4736, as well as the results of an intermediate phase II study conducted by the United States National Cancer Institute on an ovarian cancer tre...

Also read: BRIEF-Richter signs deal with DM Bio for biosimilar cancer medicine

Read more

To category page